Skip to main content
. Author manuscript; available in PMC: 2013 May 1.
Published in final edited form as: J Oral Maxillofac Surg. 2012 May;70(5):1081–1092. doi: 10.1016/j.joms.2011.05.002

Figure 2. Effects of pamidronate on osteogenic cell viability (A, B) and proliferation (C, D).

Figure 2

Figure 2

Figure 2

Figure 2

High concentrations (≥6 × 10−5 M) of pamidronate significantly affected survival and decreased cell proliferation of alveolar osteoblasts (A, C) and BMSCs (B, D) in comparison to lower concentration groups (#, p<0.05) (*, p<0.001). Data represent averages ± SD of measurements (n=4) obtained from four alveolar bone and three BMSCs samples.